ASX:PME Pro Medicus (PME) Stock Forecast, Price & News Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume285,954 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield0.43%Price TargetN/A ProfileProfileChartCompetitorsDividendInsider TradesHeadlinesProfileChartCompetitorsDividendInsider TradesHeadlines About Pro Medicus (ASX:PME) StockPro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.Read More Receive PME Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pro Medicus and its competitors with MarketBeat's FREE daily newsletter. Email Address PME Stock News HeadlinesMay 27, 2023 | finance.yahoo.comInvestors in Pro Medicus (ASX:PME) have seen fantastic returns of 726% over the past five yearsMay 25, 2023 | msn.comCRITERION: This ASX biotech is the sole dedicated player in a new $420 billion marketJune 3, 2023 | Vantage Point (Ad)We Called (ARWR) In Advance, Which Stocks Are Next?Nearly 56% gains in 30 days! This bullish trend reversal was not only forecasted by A.I., but we called it 1 – 3 days in advance. If you have any money invested in the markets…even just your retirement, you’ll want to see this. Plus, it’s FREE - the training is only an hour & LIVE. April 30, 2023 | finance.yahoo.comPro Medicus (ASX:PME) Knows How To Allocate Capital EffectivelyApril 19, 2023 | msn.comCSL shares dip despite new FDA approvalMarch 24, 2023 | finance.yahoo.comDespite recent sales, Pro Medicus Limited (ASX:PME) insiders still hold the largest share with a 53% interestMarch 16, 2023 | msn.comFounders sell off $125 million worth of this ASX 200 company’s stock. What’s going on?February 18, 2023 | msn.comASX shares: Invest in these 2 stocks for a legit chance at $1 millionJune 3, 2023 | Legacy Research (Affiliate) (Ad)“Amazon Loophole” could hand you $28,544 in “royalty” payoutsThanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.February 8, 2023 | finance.yahoo.comVisage 7 Named Best in KLAS 2023January 30, 2023 | msn.com4 ASX 200 shares hitting new 52-week highs on MondayJanuary 26, 2023 | uk.finance.yahoo.comPro Medicus Limited's (ASX:PME) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?January 23, 2023 | msn.comThis ASX 200 healthcare share just hit a new 52-week high. Here’s whyJanuary 9, 2023 | fool.com.auPro Medicus Limited shares rocket: Is this the next hot stock?December 18, 2022 | ca.finance.yahoo.comPro Medicus (ASX:PME) sheds 4.1% this week, as yearly returns fall more in line with earnings growthNovember 27, 2022 | finance.yahoo.comVisage Announces Support of Amazon HealthLake ImagingNovember 21, 2022 | yahoo.comUnder The Bonnet, Pro Medicus' (ASX:PME) Returns Look ImpressiveNovember 1, 2022 | fool.com.auTwo 5-bagger health tech ASX shares ready to rocket again: expertOctober 21, 2022 | fool.com.auThis ASX 200 share turned $10k into $1 million in just 10 yearsOctober 21, 2022 | fool.com.auThis ASX 200 share has ‘all the qualities of a compounder’: expertsOctober 14, 2022 | finance.yahoo.comInsiders at Pro Medicus Limited (ASX:PME) must be dismayed with the latest 3.3% dip after buying recentlySeptember 21, 2022 | finance.yahoo.comWith EPS Growth And More, Pro Medicus (ASX:PME) Makes An Interesting CaseSeptember 16, 2022 | markets.businessinsider.com2 ASX stocks just received a “Perfect 10” Smart ScoreSeptember 16, 2022 | markets.businessinsider.comHere’s 2 ASX stocks that just received a “Perfect 10” Smart ScoreSeptember 2, 2022 | afr.comPro Medicus LimitedAugust 21, 2022 | fool.com.auPro Medicus share price tipped to rise amid ‘strong long-term growth story’August 18, 2022 | afr.comPro Medicus dodges the tech wreck as profits soarSee More Headlines PME Company Calendar Ex-Dividend for 3/23 Dividend3/01/2023Dividend Payable3/23/2023Today6/03/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX Industry Health Information Services Sub-IndustryN/A SectorComputer and Technology Current SymbolASX:PME CUSIPN/A CIKN/A Webwww.promed.com.au Phone61 3 9429 8800FaxN/AEmployees2,060Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A$0.49 Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth3.87Net Income$50.95 million Net Margins47.77% Pretax MarginN/A Return on Equity48.05% Return on Assets27.99% Debt Debt-to-Equity Ratio1.74 Current Ratio5.50 Quick Ratio4.39 Sales & Book Value Annual Sales$106.67 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow71.76 Book ValueA$1.12 per share Price / BookN/AMiscellaneous Outstanding Shares104,430,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.58 Key ExecutivesDr. Sam Aaron Hupert M.B.B.S.M.D., Co-Founder, CEO, MD & Exec. DirectorMr. Anthony Barry Hall B.Sc.B.Sc.(Hons), M.Sc., Co-Founder, Technology Director & Exec. DirectorMr. Clayton James Hatch CPAB.Comm, CPA, CFO & Company Sec.Dr. Malte WesterhoffGM of Europe & Global CTOMr. Brad LevinGM of North America & Global Head of MarketingMr. Sean LambrightGlobal Head of Sales - Visage Imaging IncMs. Teresa GschwindGlobal Head of Customer Service of Visage Imaging Inc.More ExecutivesKey Competitors1st GroupASX:1STAlcidion GroupASX:ALCCann AmericanCNSX:CNNACogstateASX:CGSeWellness HealthcareOTCMKTS:EWLLView All CompetitorsInsidersAnthony HallSold 1,000,000 sharesTotal: $62.22 M ($62.22/share)Peter KempenSold 3,611 sharesTotal: $221,152.08 ($61.24/share)Peter KempenSold 10,000 sharesTotal: $611,920.00 ($61.19/share)Peter KempenSold 15,000 sharesTotal: $932,715.00 ($62.18/share)Alice WilliamsBought 250 shares on 8/22/2022Total: $13,440.00 ($53.76/share)View All Insider Transactions PME Stock - Frequently Asked Questions How often does Pro Medicus pay dividends? What is the dividend yield for Pro Medicus? Pro Medicus announced a Interim dividend on Thursday, March 2nd. Stockholders of record on Thursday, March 23rd will be given a dividend of 0.13 per share on Thursday, March 23rd. This represents a dividend yield of 0.22%. The ex-dividend date of this dividend is Wednesday, March 1st. This is an increase from the stock's previous Interim dividend of A$0.07. Read our dividend analysis for PME. Is Pro Medicus a good dividend stock? Pro Medicus (ASX:PME) pays an annual dividend of A$0.26 per share and currently has a dividend yield of 0.43%. The dividend payout ratio is 53.06%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for PME. What other stocks do shareholders of Pro Medicus own? Based on aggregate information from My MarketBeat watchlists, some companies that other Pro Medicus investors own include ImmuPharma (IMM), Blackmores (BKL), Bank of America (BAC), Boeing (BA), Accent Group (AX1), Axos Financial (AX), ARB (ARB), Appen (APX), Arista Networks (ANET) and Altium (ALU). What is Pro Medicus' stock symbol? Pro Medicus trades on the ASX under the ticker symbol "PME." How much money does Pro Medicus make? Pro Medicus (ASX:PME) has a market capitalization of $0.00 and generates $106.67 million in revenue each year. The company earns $50.95 million in net income (profit) each year or A$0.49 on an earnings per share basis. How many employees does Pro Medicus have? The company employs 2,060 workers across the globe. How can I contact Pro Medicus? The official website for the company is www.promed.com.au. The company can be reached via phone at 61 3 9429 8800. This page (ASX:PME) was last updated on 6/3/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pro Medicus Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.